Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells.

Authors: Cao, Zipeng; Li, Xueyong; Li, Jingxia; Kang, Beipei; Chen, Jingyuan; Luo, Wenjing; Huang, Chuanshu

Published In Mol Oncol, (2014 Mar)

Abstract: Selective activation of Rho GTPase cascade requires the release of Rho from RhoGDI (GDP-dissociation inhibitors) complexes. Our previous studies identified RhoGDIα SUMOylation at Lys-138 and its function in the regulation of cancer cell invasion. In the current study, we demonstrate that RhoGDIα SUMOylation has a crucial role in the suppression of cancer cell anchorage-independent growth as well as the molecular mechanisms underlying this suppression. We found that ectopic expression of RhoGDIα resulted in marked inhibition of an anchorage-independent growth with induction of G0/G1 cell cycle arrest, while point mutation of RhoGDIα SUMOylation at residue Lys-138 (K138R) abrogated this growth suppression and G0/G1 cell cycle arrest in cancer cells. Further studies showed that SUMOylation at Lys-138 was critical for RhoGDIα down-regulation of cyclin D1 protein expression and that MEK1/2-Erk was a specific downstream target of SUMOylated RhoGDIα for its inhibition of C-Jun/AP-1 cascade, cyclin d1 transcription, and cell cycle progression. These results strongly demonstrate that SUMOylated RhoGDIα suppressed C-Jun/AP-1-dependent transactivation specifically via targeting MEK1/2-Erk, subsequently leading to the down-regulation of cyclin D1 expression and anti-cancer activity. Our results provide new mechanistic insights into the understanding of essential role of SUMOylation at Lys-138 in RhoGDIα's biological function.

PubMed ID: 24342356 Exiting the NIEHS site

MeSH Terms: Amino Acid Substitution; Cell Line, Tumor; Cyclin D1/genetics; Cyclin D1/metabolism*; G1 Phase Cell Cycle Checkpoints*; Gene Expression Regulation, Neoplastic/genetics; Humans; MAP Kinase Signaling System/genetics; Neoplasms/genetics; Neoplasms/metabolism*; Neoplasms/pathology; Point Mutation*; Proto-Oncogene Proteins c-jun/genetics; Proto-Oncogene Proteins c-jun/metabolism; Sumoylation*; Transcription, Genetic/genetics; rho Guanine Nucleotide Dissociation Inhibitor alpha/genetics; rho Guanine Nucleotide Dissociation Inhibitor alpha/metabolism*

to Top